✦ LIBER ✦

Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib

✍ Scribed by Y. Mishima; Y. Terui; K. Takeuchi; E. Nagasaki; M. Yokoyama; N. Mizunuma; S. Takahashi; K. Yamada; T. Fukunaga; J. Yamamoto; T. Yamaguchi; Y. Kato; K. Hatake

Book ID: 107384256
Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 201 KB
Volume: 1
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-006-0021-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistent neutropenia in chronic myelog

Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

✍ Yu-Yan Hwang; Eric Tse; Jason C.C. So; Thomas S.K. Wan; Yok-Lam Kwong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

A physician or a group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary.

Exacerbation of psoriasis in a chronic m

Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib

✍ Seung Man WOO; Chang Hun HUH; Kyung Chan PARK; Sang Woong YOUN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB

Correlation of immunophenotype with prog

Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate

✍ Lucian R. Chirieac; Jonathan C. Trent; Dejka M. Steinert; Haesun Choi; Ying Yang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

Molecular and cytogenetic response of ch

Molecular and cytogenetic response of chronic myelogenous leukemia treated with imatinib mesylate: one institutional experience in Japan

✍ Yasuhito Nannya; Hiromitsu Yokota; Yumiko Sato; Go Yamamoto; Takashi Asai; Motos 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 255 KB

Clinical course of thrombocytopenia in p

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia

✍ Hendrik W. van Deventer; Melissa D. Hall; Robert Z. Orlowski; Beverly S. Mitchel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Expression of Bcl-2 in gastrointestinal

Expression of Bcl-2 in gastrointestinal stromal tumors : Correlation with progression-free survival in 81 patients treated with imatinib mesylate

✍ Dejka M. Steinert; Mauricio Oyarzo; Xuemei Wang; Haesun Choi; Peter F. Thall; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract ## BACKGROUND The natural history of gastrointestinal stromal tumor (GIST) has been revolutionized by imatinib mesylate (imatinib) therapy. Before imatinib, Bcl‐2 expression in GIST was associated with a worse prognosis or added no additional prognostic value. To the authors' knowledge